As parity did not prevent tumors in BALB/c-Trp53-/- mammary epithelial transplants [22], the decrease in mammary tumors among parous BALB/c-Trp53+/- (Figure 6b) appears to be largely p53-dependent. Here, TP53 is linked to breast cancer.